<inglise> COMMISSION REGULATION (EEC) No 3600/92 of 11 December 1992 laying down the detailed rules for the implementation of the first stage of the programme of work referred to in Article 8 (2) of Council Directive 91/414/EEC concerning the placing of plant protection products on the market </inglise>
<eesti> KOMISJONI M&Auml;&Auml;RUS (EM&Uuml;) nr 3600/92, millega n&auml;hakse ette taimekaitsevahendite turuleviimist k&auml;sitleva n&otilde;ukogu direktiivi 91/414/EM&Uuml; artikli 8 l&otilde;ikes 2 osutatud t&ouml;&ouml;programmi esimese etapi &uuml;ksikasjalikud rakenduseeskirjad 11. detsember 1992 </eesti>
<inglise> THE COMMISSION OF THE EUROPEAN COMMUNITIES, </inglise>
<eesti> EUROOPA &Uuml;HENDUSTE KOMISJON, </eesti>
<inglise> Having regard to the Treaty establishing the European Economic Community, </inglise>
<eesti> v&otilde;ttes arvesse Euroopa Majandus&uuml;henduse asutamislepingut, </eesti>
<inglise> Having regard to Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market (1), and in particular Article 8 (2) thereof, </inglise>
<eesti> v&otilde;ttes arvesse n&otilde;ukogu 15. juuli 1991. aasta direktiivi 91/414/EM&Uuml; taimekaitsevahendite turuleviimise kohta, (1) eriti selle artikli 8 l&otilde;iget 2, ning arvestades, et: </eesti>
<inglise> Whereas the Commission is to commence a programme of work for the gradual examination of active substances available on the market two years after the date of notification of Directive 91/414/EEC; </inglise>
<eesti> komisjon peab k&auml;ivitama t&ouml;&ouml;programmi, et j&auml;rkj&auml;rgult asuda kontrollima toimeaineid, mis on turul saadaval kaks aastat p&auml;rast direktiivist 91/414/EM&Uuml; teavitamisest; </eesti>
<inglise> Whereas, given the very high number of active substances on the market on that date, a selection has already been made, taking into account in a balanced manner such aspects as health and/or environmental concern, the possibility of residues in treated products, the importance of the preparations containing these substances for agriculture, any manifest data gaps (or, conversely, the presence of a complete, updated data package), and any similarity of chemical or biological properties; </inglise>
<eesti> kuna sel ajal turul olevate toimeainete hulk on v&auml;ga suur, on valik juba tehtud, arvestades v&otilde;rdselt selliseid aspekte nagu tervise- ja/v&otilde;i keskkonnakaitse, t&ouml;&ouml;deldud toodetes sisalduvad v&otilde;imalikud j&auml;&auml;kained, k&otilde;nealuseid toimeaineid sisaldavate preparaatide t&auml;htsus p&otilde;llumajanduses, kasutusel olevate andmete ilmsed puudused (v&otilde;i vastupidi, terviklike ja ajakohaste andmete olemasolu) ning keemiliste v&otilde;i bioloogiliste omaduste sarnasus; </eesti>
<inglise> Whereas the relationship between producers, Member States and the Commission and the obligations on each of the parties for the implementation of the programme should be laid down; </inglise>
<eesti> s&auml;testada tuleb tootjate, liikmesriikide ja komisjoni omavahelised suhted ning k&otilde;ikide osapoolte kohustused programmi rakendamisel; </eesti>
<inglise> Whereas a notification procedure has to be provided by which interested producers have the right to inform the Commission of their interest in securing the inclusion of an active substance in Annex I to the Directive and of their undertaking to submit all the requisite information for a proper evaluation of, and decision on, that active substance in the light of the criteria for inclusion set out in Article 5 of Directive 91/414/EEC; </inglise>
<eesti> ette tuleb n&auml;ha teatamise kord, mille kohaselt huvitatud tootjatel on &otilde;igus teavitada komisjoni oma soovist kanda toimeaine direktiivi I lisasse ning kohustusest esitada k&otilde;ik andmed, mis on vajalikud, et k&otilde;nealust toimeainet direktiivi 91/4141/EM&Uuml; artikliga 5 kehtestatud kriteeriumide seisukohalt hinnata ning teha lisamise kohta otsus; </eesti>
<inglise> Whereas it is necessary to define the obligations of notifiers with regard to the formats, the periods and the recipient authorities for the information to be submitted; whereas the administrative consequences which shall follow if these obligations are not satisfied have to be defined; </inglise>
<eesti> m&auml;&auml;ratleda tuleb teatajate kohustused esitatava teabe vormi, t&auml;htaegade ja teavet saava asutuse suhtes; m&auml;&auml;ratleda tuleb k&otilde;nealuste kohustuste t&auml;itmataj&auml;tmisest tulenevad haldustagaj&auml;rjed; </eesti>
<inglise> Whereas technical or scientific information about the potentially dangerous effects of an active substance or its residues submitted within the relevant time-limits by any other interested parties should also be taken into consideration for this evaluation; </inglise>
<eesti> hindamisel tuleb arvesse v&otilde;tta ka etten&auml;htud t&auml;htaegade jooksul k&otilde;ikide teiste huvitatud poolte esitatud tehnilisi v&otilde;i teaduslikke andmeid toimeaine v&otilde;i selle j&auml;&auml;kide v&otilde;imalike kahjulike m&otilde;jude kohta; </eesti>
<inglise> Whereas the evaluation studies should be distributed among the competent authorities of the Member States; whereas, therefore, for each active substance a rapporteur Member State should be designated to examine and evaluate the information submitted, in close consultation with experts from other Member States, and to present to the Commission the results of the assessment and a recommendation that a decision be taken with regard to the active substance concerned; </inglise>
<eesti> hindamisuuringud tuleb jagada liikmesriikide p&auml;devate asutuste vahel; seep&auml;rast tuleb iga toimeaine jaoks m&auml;&auml;rata referentliikmesriik, kes tihedas koost&ouml;&ouml;s teiste liikmesriikide ekspertidega vaatab l&auml;bi esitatud andmed, hindab neid, esitab komisjonile hindamistulemused ja soovitab, milline otsus teha asjaomase toimeaine kohta; </eesti>
<inglise> Whereas the proceedings established under this Regulation should not prejudice proceedings to be undertaken in the framework of other Community legislations; </inglise>
<eesti> k&auml;esoleva m&auml;&auml;rusega kehtestatud menetlused ei piira muude &uuml;henduse &otilde;iguse raames etten&auml;htud menetluste kohaldamist; </eesti>
<inglise> Whereas, in order to avoid duplication of work, and in particular experiments involving vertebrate animals, specific provisions have to be provided to stimulate producers to submit collective dossiers; </inglise>
<eesti> selleks et v&auml;ltida t&ouml;&ouml; kattumist, eelk&otilde;ige selgroogsete loomadega tehtavaid katseid, tuleb ette n&auml;ha eris&auml;tted, soodustamaks tootjate &uuml;hist toimikute esitamist; </eesti>
<inglise> Whereas the procedures under the Regulation should not prejudice the possibility of investigation and prohibitory action under Council Directive 79/117/EEC (2), as last amended by Commission Directive 91/188/EEC (3), where information becomes available to the Commission showing that the requirements for prohibition provided for in Directive 79/117/EEC may be satisfied; whereas at the time of adoption of this Regulation such information regarding Atrazin and Quintozene is under particular examination; </inglise>
<eesti> k&auml;esoleva m&auml;&auml;ruse kohased menetlused ei piira n&otilde;ukogu direktiiviga 79/117/EM&Uuml; (2) (viimati muudetud komisjoni direktiiviga 91/188/EM&Uuml; (3)) etten&auml;htud uuringuid ja v&otilde;imalikku keeldude kohaldamist, kui komisjoni k&auml;sutuses on andmed, mis osutavad sellele, et direktiiviga 79/117/EM&Uuml; etten&auml;htud keeld on p&otilde;hjendatud; k&auml;esoleva m&auml;&auml;ruse vastuv&otilde;tmise ajal kontrollitakse eriti hoolikalt atraziini ja kintoseeniga seonduvat teavet; </eesti>
<inglise> Whereas procedural and administrative measures have to be taken at this time in order to ensure that the evaluation of active substances can effectively start from the date of implementation of Directive 91/414/EEC; </inglise>
<eesti> sel ajal tuleb v&otilde;tta menetlus- ja haldusmeetmed, et tagada toimeainete t&otilde;husa hindamise k&auml;ivitumine alates direktiivi 91/414/EM&Uuml; rakendamiskuup&auml;evast; </eesti>
<inglise> Whereas the measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plant Health, </inglise>
<eesti> k&auml;esoleva m&auml;&auml;rusega etten&auml;htud meetmed on koosk&otilde;las alalise taimetervise komitee arvamusega, </eesti>
<inglise> HAS ADOPTED THIS REGULATION: </inglise>
<eesti> ON VASTU V&Otilde;TNUD K&Auml;ESOLEVA M&Auml;&Auml;RUSE. </eesti>
<inglise> Article 1 </inglise>
<eesti> Artikkel 1 </eesti>
<inglise> 1. </inglise>
<eesti> 1. </eesti>
<inglise> This Regulation lays down detailed rules for the implementation of the first stage of the programme of work referred to in Article 8 (2) of Directive 91/414/EEC (hereinafter referred to as 'the Directive'). </inglise>
<eesti> K&auml;esoleva m&auml;&auml;rusega n&auml;hakse ette direktiivi 91/414/EM&Uuml; (edaspidi direktiivi) artikli 8 l&otilde;ikes 2 osutatud t&ouml;&ouml;programmi esimese etapi &uuml;ksikasjalikud rakenduseeskirjad. </eesti>
<inglise> The first stage involves an assessment of the substances listed in Annex I to this Regulation with a view to their possible inclusion in Annex I to Directive 91/414/EEC. </inglise>
<eesti> Esimene etapp h&otilde;lmab k&auml;esoleva m&auml;&auml;ruse I lisas loetletud ainete hindamist eesm&auml;rgiga kanda need v&otilde;imaluse korral direktiivi 91/414/EM&Uuml; I lisasse. </eesti>
<inglise> The provisions of Article 6 (2) and (3) and the second subparagraph of Article 6 (4) of the Directive shall not apply to a substance listed in Annex I to this Regulation as long as the procedures provided in this Regulation with regard to such substance have not been finalized. </inglise>
<eesti> Direktiivi artikli 6 l&otilde;igete 2 ja 3 ning artikli 6 l&otilde;ike 4 teise l&otilde;igu s&auml;tteid ei kohaldata k&auml;esoleva m&auml;&auml;ruse I lisas loetletud ainete suhtes seni, kuni selle aine suhtes k&auml;esoleva m&auml;&auml;rusega etten&auml;htud menetlused ei ole l&otilde;petatud. </eesti>
<inglise> 2. </inglise>
<eesti> 2. </eesti>
<inglise> This Regulation shall apply without prejudice to: </inglise>
<eesti> K&auml;esoleva m&auml;&auml;ruse kohaldamine ei piira: </eesti>
<inglise> (a) reviews conducted by Member States, and in particular reviews with a view to authorization renewals under Article 4 (4) of the Directive; </inglise>
<eesti> a) liikmesriikidepoolset kontrollimist, eelk&otilde;ige k&otilde;nealuse direktiivi artikli 4 l&otilde;ike 4 kohast lubade uuendamisega seotud kontrollimist; </eesti>
<inglise> (b) reviews by the Commission pursuant to Article 5 (5) of the Directive; </inglise>
<eesti> b) direktiivi artikli 5 l&otilde;ike 5 kohast komisjonipoolset kontrollimist; </eesti>
<inglise> (c) assessments carried out under Directive 79/117/EEC. </inglise>
<eesti> c) direktiivi 79/117/EM&Uuml; kohaseid hindamisi. </eesti>
<inglise> Article 2 </inglise>
<eesti> Artikkel 2 </eesti>
<inglise> 1. </inglise>
<eesti> 1. </eesti>
<inglise> For the purpose of this Regulation, 'plant protection products', 'substances', 'active substances', 'preparations' and 'authorization of a plant protection product' shall have the meanings set out in Article 2 of the Directive. </inglise>
<eesti> K&auml;esolevas m&auml;&auml;ruses kasutatakse m&otilde;isteid "taimekaitsevahendid", "ained", "toimeained", "preparaadid" ja "taimekaitsevahendite lubamine" direktiivi artiklis 2 esitatud t&auml;henduses. </eesti>
<inglise> 2. </inglise>
<eesti> 2. </eesti>
<inglise> The following definitions shall also apply for the purpose of this Regulation: </inglise>
<eesti> K&auml;esolevas m&auml;&auml;ruses kasutatakse ka j&auml;rgmisi m&otilde;isteid: </eesti>
<inglise> (a) 'Producers' means </inglise>
<eesti> a) tootjad: </eesti>
<inglise> - for active substances produced within the Community, the manufacturer or a person established within the Community designated by the manufacturer as his sole representative, </inglise>
<eesti> - &uuml;henduses toodetud toimeainete puhul nende valmistaja v&otilde;i tema m&auml;&auml;ratud &uuml;henduses registrisse kantud ainuesindaja, </eesti>
<inglise> - for active substances produced outside the Community, the person established within the Community and designated by the manufacturer as his sole representative or, whenever such person has not been designated, the importer(s) into the Community of the active substance, either on its own or in a preparation; </inglise>
<eesti> - v&auml;ljaspool &uuml;hendust toodetud toimeainete puhul valmistaja m&auml;&auml;ratud &uuml;henduses registrisse kantud ainuesindaja, v&otilde;i kui sellist isikut ei ole m&auml;&auml;ratud, siis toimeainete v&otilde;i neid sisaldavate preparaatide &uuml;hendusse importija v&otilde;i importijad; </eesti>
<inglise> (b) 'Committee' means the Standing Committee on Plant Health, referred to in Article 19 of the Directive. </inglise>
<eesti> b) komitee - direktiivi artiklis 19 osutatud alaline taimetervise komitee. </eesti>
<inglise> Article 3 </inglise>
<eesti> Artikkel 3 </eesti>
<inglise> Member States shall designate an authority to coordinate cooperation with producers, other Member States and the Commission, and generally for the implementation of the programme of work referred to in Article 8 (2) of the Directive. </inglise>
<eesti> Liikmesriigid m&auml;&auml;ravad asutuse, kes koordineerib koost&ouml;&ouml;d tootjate, teiste liikmesriikide ja komisjoni vahel ning direktiivi artikli 8 l&otilde;ikes 2 osutatud t&ouml;&ouml;programmi &uuml;ldist rakendamist. </eesti>
<inglise> They shall inform the Commission of the name of the designated authority. </inglise>
<eesti> Nad teatavad komisjonile m&auml;&auml;ratud asutuse nime. </eesti>
<inglise> Article 4 </inglise>
<eesti> Artikkel 4 </eesti>
<inglise> 1. </inglise>
<eesti> 1. </eesti>
<inglise> Any producer wishing to secure the inclusion of an active substance referred to in Annex I hereto, or any salts, esters or amines thereof, in Annex I to the Directive, shall so notify the Commission within six months of the date of entry into force of this Regulation. </inglise>
<eesti> K&otilde;ik tootjad, kes soovivad, et k&otilde;nealuse direktiivi I lisasse kantaks m&otilde;ni k&auml;esoleva m&auml;&auml;ruse I lisas osutatud toimeaine v&otilde;i selle soolad, estrid v&otilde;i aminoderivaadid, teatavad sellest komisjonile kuue kuu jooksul alates k&auml;esoleva m&auml;&auml;ruse j&otilde;ustumiskuup&auml;evast. </eesti>
<inglise> Without prejudice to the foregoing subparagraph, producers of an active substance listed in Annex I are also bound to inform the Commission within the same period when they no longer seek its inclusion in Annex I to the Directive. </inglise>
<eesti> Ilma et see piiraks eelmise l&otilde;igu kohaldamist, peavad I lisas loetletud toimeaine tootjad sama ajavahemiku jooksul komisjoni teavitama ka sellest, kui nad enam ei soovi aine kandmist direktiivi I lisasse. </eesti>
<inglise> 2. </inglise>
<eesti> 2. </eesti>
<inglise> Notification must be made to the Commission, DG VI, rue de la Loi 200, B-1049 Brussels, in accordance with the notification as shown in Annex II hereto, completed and containing the undertaking referred to in part 5 of the specimen notification. </inglise>
<eesti> Komisjonile teatamiseks tuleb t&auml;ita k&auml;esoleva m&auml;&auml;ruse II lisas esitatud teaten&auml;idis, mis sisaldab n&auml;idise 5. osas nimetatud kohustust, ja saata aadressil DG VI, Rue de la Loi, B-1049 Brussels. </eesti>
<inglise> 3. </inglise>
<eesti> 3. </eesti>
<inglise> Any producer who has not notified in time any given active substance referred to in paragraph 1 will be permitted to participate in the programme referred to in Article 1 only collectively with other notifiers of that active substance or, in the case referred to in paragraph 4 hereof, in assisting the notifying Member State, with the agreement of the original notifiers. </inglise>
<eesti> Tootja, kes ei ole &otilde;igel ajal teatanud m&otilde;nest l&otilde;ikes 1 osutatud toimeainest, v&otilde;ib osaleda artiklis 1 nimetatud programmis ainult koos teiste k&otilde;nealusest toimeainest teatajatega v&otilde;i, kui on tegemist l&otilde;ikes 4 osutatud juhtumiga, abistada teate esitanud liikmesriiki algsete teatajate n&otilde;usolekul. </eesti>
<inglise> 4. </inglise>
<eesti> 4. </eesti>
<inglise> The Commission shall inform the Member States through the Committee when, for any given active substance, no producer has presented a notification in accordance with paragraph 2. </inglise>
<eesti> Komisjon teavitab liikmesriike komitee kaudu, kui m&otilde;ne toimeaine kohta ei ole &uuml;kski tootja esitanud l&otilde;ike 2 kohast teadet. </eesti>
<inglise> Member States shall be able to declare their interest in securing the inclusion of the active substance in Annex I to the Directive, by means of the specimen notification shown in Annex II hereto. </inglise>
<eesti> Liikmesriigid v&otilde;ivad v&auml;ljendada oma soovi kanda k&otilde;nealune toimeaine direktiivi I lisasse k&auml;esoleva m&auml;&auml;ruse II lisas esitatud teaten&auml;idisega. </eesti>
<inglise> Notification must be sent to the Commission as quickly as possible, and no later than six months after the Member States have been informed by the Commission. </inglise>
<eesti> Teade tuleb saata komisjonile v&otilde;imalikult kiiresti ja hiljemalt kuue kuu jooksul p&auml;rast seda, kui komisjon on liikmesriike teavitanud. </eesti>
<inglise> The Member State having presented the notification shall carry out the duties of a producer as set out in Articles 5 to 8 hereof. </inglise>
<eesti> Teate esitanud liikmesriik t&auml;idab k&auml;esoleva m&auml;&auml;ruse artiklites 5-8 tootjale etten&auml;htud kohustused. </eesti>
<inglise> 5. </inglise>
<eesti> 5. </eesti>
<inglise> When, following the above procedure, no producer or Member State has notified an interest in obtaining the inclusion of a given active substance in Annex I to the Directive, a decision not to include that active substance may be taken in accordance with the final subparagraph of Article 8 (2) of the Directive. </inglise>
<eesti> Kui p&auml;rast nimetatud menetlust &uuml;kski tootja ega liikmesriik ei ole teatanud oma soovist kanda teatav toimeine direktiivi I lisasse, v&otilde;idakse koosk&otilde;las direktiivi artikli 8 l&otilde;ike 2 viimase l&otilde;iguga teha otsus, et k&otilde;nealust toimeainet sinna ei kanta. </eesti>
<inglise> Article 5 </inglise>
<eesti> Artikkel 5 </eesti>
<inglise> 1. </inglise>
<eesti> 1. </eesti>
<inglise> The Commission shall examine with the Committee the notifications referred to in Article 4 (2) and (4). </inglise>
<eesti> Komisjon vaatab koos komiteega l&auml;bi artikli 4 l&otilde;igetes 2 ja 4 nimetatud teated. </eesti>
<inglise> 2. </inglise>
<eesti> 2. </eesti>
<inglise> Following the examination referred to in paragraph 1, decisions shall be adopted on the following, according to the procedure under Article 19 of the Directive, in the form of a regulation: </inglise>
<eesti> P&auml;rast l&otilde;ikes 1 osutatud l&auml;bivaatamist v&otilde;etakse direktiivi artiklis 19 etten&auml;htud korras vastu m&auml;&auml;ruse vormis otsused: </eesti>
<inglise> (a) the list of active substances adopted for assessment with a view to their possible inclusion in Annex I to the Directive; </inglise>
<eesti> a) hindamiseks v&otilde;etavate toimeainete loendi kohta, et need ained v&otilde;imaluse korral kanda direktiivi I lisasse; </eesti>
<inglise> (b) designation of a rapporteur Member State for each active substance included in the list referred to in (a). </inglise>
<eesti> b) referentliikmesriigi m&auml;&auml;ramise kohta iga punktis a nimetatud loendi toimeaine jaoks. </eesti>
<inglise> 3. </inglise>
<eesti> 3. </eesti>
<inglise> In the list referred to in paragraph 2 (a), certain substances with similar structures or chemical properties may be grouped together; if an active substance has been notified with different compositions which may lead to different toxicological properties or have different environmental effects, these may be listed separately. </inglise>
<eesti> L&otilde;ike 2 punktis a osutatud loendis v&otilde;ib teatavaid sarnaste struktuuride v&otilde;i keemiliste omadustega aineid grupeerida; kui &uuml;he toimeaine kohta on teatatud eri koostised, mille tulemuseks v&otilde;ivad olla erinevad toksikoloogilised omadused v&otilde;i keskkonnam&otilde;jud, v&otilde;ib neid nimekirjas m&auml;rkida eraldi. </eesti>
<inglise> 4. </inglise>
<eesti> 4. </eesti>
<inglise> For each substance adopted for assessment, the regulation referred to in paragraph 2 shall give: </inglise>
<eesti> K&otilde;ikide hindamiseks v&otilde;etavate ainete kohta sisaldab l&otilde;ikes 2 osutatud m&auml;&auml;rus j&auml;rgmist: </eesti>
<inglise> - the names of all producers who have presented a notification in accordance with Article 2 (1), or, where appropriate, the Member States which have presented a notification under Article 4 (4), </inglise>
<eesti> - k&otilde;ikide artikli 2 l&otilde;ike 1 kohaselt teatanud tootjate nimed v&otilde;i vajaduse korral artikli 4 l&otilde;ike 4 kohase teate esitanud liikmesriik, </eesti>
<inglise> - the name of the Member State designated as rapporteur, </inglise>
<eesti> - referendiks m&auml;&auml;ratud liikmesriik, </eesti>
<inglise> - the deadline for the submission to the rapporteur Member State of the dossiers referred to in Article 6 hereof, generally laying down a period of 12 months for the compilation of the documents, and for the submission by any interested parties of technical or scientific information with regard to the potentially dangerous effects of the substance or its residues on human and/or animal health and/or on the environment. </inglise>
<eesti> - t&auml;htaeg referentliikmesriigile k&auml;esoleva m&auml;&auml;ruse artiklis 6 osutatud toimikute esitamiseks, kusjuures &uuml;ldiselt j&auml;etakse dokumentide koostamiseks aega 12 kuud, ning t&auml;htaeg k&otilde;ikidele huvitatud pooltele nende tehniliste ja teaduslike andmete esitamiseks, mis k&auml;sitlevad aine v&otilde;i selle j&auml;&auml;kide v&otilde;imalikku kahjulikku m&otilde;ju inimeste ja/v&otilde;i loomade tervisele ja/v&otilde;i keskkonnale. </eesti>
<inglise> 5. </inglise>
<eesti> 5. </eesti>
<inglise> When, during the reassessment referred to in Articles 6, 7 and 8 hereof, an imbalance becomes apparent in the responsibilities borne by the Member States as rapporteurs, it may be decided, using the procedure under Article 19 of the Directive, to designate a different Member State as rapporteur for a particular substance. </inglise>
<eesti> Kui m&auml;&auml;ruse artiklites 6, 7 ja 8 osutatud &uuml;mberhindamise jooksul ilmneb, et referentliikmesriikide kohustused ei ole tasakaalus, v&otilde;idakse otsustada direktiivi artiklis 19 etten&auml;htud korras m&auml;&auml;rata teatava aine jaoks teine referentliikmesriik. </eesti>
<inglise> Article 6 </inglise>
<eesti> Artikkel 6 </eesti>
<inglise> 1. </inglise>
<eesti> 1. </eesti>
<inglise> Within the time-limit referred to in the third indent of Article 5 (4), the notifiers specified in the regulation referred to in that Article must, individually or collectively, send to the designated authority of the rapporteur Member State, for any given active substance: </inglise>
<eesti> Artikli 5 l&otilde;ike 4 kolmandas taandes osutatud t&auml;htaja jooksul peavad k&otilde;nealuses artiklis osutatud m&auml;&auml;rusega nimetatud teatajad eraldi v&otilde;i &uuml;hiselt saatma referentliikmesriigi m&auml;&auml;ratud asutusele iga toimeaine kohta: </eesti>
<inglise> (a) the summary dossier referred to in paragraph 2 hereof; and </inglise>
<eesti> a) k&auml;esoleva artikli l&otilde;ikes 2 osutatud koondtoimiku ja </eesti>
<inglise> (b) the complete dossier referred to in paragraph 3 hereof. </inglise>
<eesti> b) k&auml;esoleva artikli l&otilde;ikes 3 osutatud t&auml;ieliku toimiku. </eesti>
<inglise> They shall also send this information to the experts as referred to in Article 7 (2), and, if so requested, to the competent authority referred to in Article 3 of each Member State. </inglise>
<eesti> Nad saadavad k&otilde;nealused andmed ka artikli 7 l&otilde;ikes 2 osutatud ekspertidele ja vajaduse korral artiklis 3 osutatud iga liikmesriigi p&auml;devale asutusele. </eesti>
<inglise> Where for any substance the regulation as envisaged in Article 5 (4) indicates several notifications, the notifiers concerned shall take all reasonable steps to present collectively the dossiers referred to in the first subparagraph. </inglise>
<eesti> Kui artikli 5 l&otilde;ike 4 kohaselt kavandatud m&auml;&auml;ruses on &uuml;he aine kohta esitatud mitu teadet, kohustuvad teatajad tegema k&otilde;ik p&otilde;hjendatud j&otilde;upingutused, et esitada esimeses l&otilde;igus osutatud toimikud &uuml;hiselt. </eesti>
<inglise> Where a dossier was not presented by all notifiers concerned, it shall mention the efforts made and the reasons why certain producers have not participated. </inglise>
<eesti> Kui k&otilde;ik asjaomased teatajad ei ole osalenud toimiku esitamisel, tuleb m&auml;rkida tehtud j&otilde;upingutused ja p&otilde;hjused, miks teatavad tootjad ei ole seda teinud. </eesti>
<inglise> 2. </inglise>
<eesti> 2. </eesti>
<inglise> The summary dossier shall include the following: </inglise>
<eesti> Koondtoimik sisaldab j&auml;rgmist: </eesti>
<inglise> (a) a copy of the notification; in the case of a joint application made by several producers, a copy of the notifications presented in accordance with Article 4 and the name of the person designated by the producers concerned as being responsible for the joint dossier and the processing of the dossier in accordance with this Regulation; </inglise>
<eesti> a) teate koopia; mitme tootja &uuml;hisesildise korral artikli 4 kohaselt esitatud teadete koopiad ja selle isiku nimi, kelle asjaomased tootjad on m&auml;&auml;ranud vastutama &uuml;hise toimiku ning selle t&ouml;&ouml;tlemise eest vastavalt k&auml;esolevale m&auml;&auml;rusele; </eesti>
<inglise> (b) the recommended conditions for the use of an active substance, to be considered in relation to its inclusion in Annex I to the Directive; </inglise>
<eesti> b) soovitused toimeaine kasutamistingimuste kohta, mida v&otilde;etakse arvesse aine kandmisel direktiivi I lisasse; </eesti>
<inglise> (c) for each point of Annex II to the Directive, the available summaries and results of trials, the name of the person or institute that has carried out the trials; the same information for each point of Annex III to the Directive relevant to the assessment of the criteria referred to in Article 5 of the Directive and for one or more preparations which are representative for the conditions of use referred to in subparagraph (b); </inglise>
<eesti> c) direktiivi II lisa iga punkti kohta olemasolevad kokkuv&otilde;tted ja katsetulemused ning katseid teinud isiku v&otilde;i asutuse nimi; samad andmed direktiivi III lisa iga punkti kohta, mis on olulised hindamisel direktiivi artiklis 5 osutatud kriteeriumide seisukohalt, ning &uuml;he v&otilde;i mitme preparaadi kohta, mis on tavap&auml;rased alapunktis b osutatud kasutamistingimustes; </eesti>
<inglise> (d) when the information referred to in certain points of subparagraph (c) is not available: </inglise>
<eesti> d) kui teatavad punktis c osutatud andmed puuduvad: </eesti>
<inglise> - either, in accordance with the introductory provisions of Annexes II and III of the Directive, the scientific or technical reasons demonstrating that the information is not necessary for the assessment of the active substance according to the criteria referred to in Article 5 of the Directive, </inglise>
<eesti> - siis kas direktiivi II ja III lisa sissejuhatavate s&auml;tete kohased teaduslikud v&otilde;i tehnilised p&otilde;hjendused, mis kinnitavad, et k&otilde;nealused andmed ei ole direktiivi artiklis 5 osutatud kriteeriumide seisukohalt toimeaine hindamiseks vajalikud; </eesti>
<inglise> - or an undertaking by the producer or producers submitting the dossier that the missing information will be sent at a later date; a detailed timetable and documents showing that the undertaking can be fulfilled must be submitted. </inglise>
<eesti> - v&otilde;i toimiku esitanud tootja v&otilde;i tootjate kohustus saata puuduvad andmed hiljem; esitada tuleb &uuml;ksikasjalik ajakava ning kohustuse t&auml;itmise v&otilde;imalikkust kinnitavad dokumendid. </eesti>
<inglise> 3. </inglise>
<eesti> 3. </eesti>
<inglise> The complete dossier shall contain the protocols and the complete study reports concerning all the information referred to in paragraph 2 (c). </inglise>
<eesti> T&auml;ielik toimik sisaldab k&otilde;ikide l&otilde;ike 2 punktis c osutatud andmetega seotud protokolle ja t&auml;ielikke uurimisaruandeid. </eesti>
<inglise> 4. </inglise>
<eesti> 4. </eesti>
<inglise> Where, for any given active substance, the dossiers referred to in paragraph 1 are not sent within the time-limit laid down in Article 5 (4) or where the dossiers sent clearly do not satisfy the requirements laid down in paragraphs 2 and 3 hereof, the rapporteur Member State shall inform the Commission, giving the reasons pleaded by the notifiers. </inglise>
<eesti> Kui m&otilde;ne toimeaine kohta ei ole l&otilde;ikes 1 osutatud toimikuid saadetud artikli 5 l&otilde;ikes 4 nimetatud t&auml;htaja jooksul v&otilde;i kui saadetud toimikud selgelt ei vasta l&otilde;igetega 2 ja 3 etten&auml;htud n&otilde;uetele, teatab referentliikmesriik sellest komisjonile, esitades teatajate p&otilde;hjendused. </eesti>
<inglise> 5. </inglise>
<eesti> 5. </eesti>
<inglise> On the basis of the report of the rapporteur Member State referred to in paragraph 4, the Commission shall present to the Committee a draft decision not to include the active substance in Annex I, in accordance with the final subparagraph of Article 8 (2) of the Directive, unless: </inglise>
<eesti> L&otilde;ikes 4 osutatud referentliikmesriigi aruande p&otilde;hjal esitab komisjon komiteele otsuse eeln&otilde;u j&auml;tta k&otilde;nealune toimeaine direktiivi artikli 8 l&otilde;ike 2 viimase l&otilde;igu kohaselt I lisasse kandmata, v&auml;lja arvatud siis, kui: </eesti>
<inglise> - a new time-limit has been granted for the submission of a dossier fulfilling the requirements of paragraphs 2 and 3; a new time-limit willl only be granted where the delay is proved to have been caused by efforts to present collective dossiers or by force majeure, </inglise>
<eesti> - m&auml;&auml;ratakse uus t&auml;htaeg l&otilde;igete 2 ja 3 n&otilde;uetele vastava toimiku esitamiseks; uus t&auml;htaeg m&auml;&auml;ratakse ainult sel juhul, kui on t&otilde;estatud, et viivituse on p&otilde;hjustanud &uuml;hise toimiku esitamisega seotud raskused v&otilde;i v&auml;&auml;ramatu j&otilde;ud, </eesti>
<inglise> - a Member State informs the Commission of its wish to secure the inclusion of the active substance concerned in Annex I to the Directive and its readiness to ensure the composition of the dossiers as referred to in paragraph 1 hereof and to carry out the duties of notifier as set out in Articles 7 and 8 hereof. </inglise>
<eesti> - liikmesriik teavitab komisjoni oma soovist kanda k&otilde;nealune toimeaine direktiivi I lisasse ja oma valmisolekust tagada k&auml;esoleva artikli l&otilde;ikes 1 osutatud toimikute koostamine ning t&auml;ita artikli 7 ja 8 kohaselt teataja kohustused. </eesti>
<inglise> Article 7 </inglise>
<eesti> Artikkel 7 </eesti>
<inglise> 1. </inglise>
<eesti> 1. </eesti>
<inglise> For each active substance for which it has been designated rapporteur, the Member State shall: </inglise>
<eesti> Iga toimeaine puhul, mille suhtes liikmesriik on m&auml;&auml;ratud referendiks, toimib ta j&auml;rgmiselt: </eesti>
<inglise> (a) examine the dossiers referred to in Article 6 (2) and (3), in the order in which they are received from the notifier or notifiers concerned, as well as any information as referred to in the third indent of Article 5 (4) and any other available information; if several dossiers are presented for one active substance, the dossier presented last will determine the order of its examination; </inglise>
<eesti> a) vaatab l&auml;bi artikli 6 l&otilde;igetes 2 ja 3 osutatud toimikud vastavalt asjaomaselt teatajalt v&otilde;i teatajatelt saabumise j&auml;rjekorrale, samuti k&otilde;ik artikli 5 l&otilde;ike 4 kolmandas taandes osutatud andmed ning muud olemasolevad andmed; kui &uuml;he toimeaine kohta esitatakse mitu toimikut, on selle aine l&auml;bivaatamise j&auml;rjekorra kindlaksm&auml;&auml;ramisel otsustava t&auml;htsusega k&otilde;ige viimasena esitatud toimik; </eesti>
<inglise> (b) immediately after examining a dossier, ensure that notifiers submit the updated summary dossier to the other Member States and to the Commission; </inglise>
<eesti> b) tagab kohe p&auml;rast toimiku l&auml;bivaatamist, et teatajad esitaksid toimiku ajakohastatud kokkuv&otilde;tte teistele liikmesriikidele ja komisjonile; </eesti>
<inglise> (c) send the Commission, as quickly as possible and at the latest 12 months after receipt of a dossier as referred to in Article 6 (2) and (3), a report of its assessment of the dossier, including a recommendation: </inglise>
<eesti> c) saadab komisjonile v&otilde;imalikult kiiresti ja hiljemalt 12 kuu jooksul p&auml;rast artikli 6 l&otilde;igetes 2 ja 3 osutatud toimiku saamist toimiku hindamisaruande, mis sisaldab soovitust: </eesti>
<inglise> - to include the active substance in Annex I to the Directive, stating the conditions for its inclusion, or </inglise>
<eesti> - kanda k&otilde;nealune toimeaine direktiivi I lisasse, t&auml;psustades tingimused, v&otilde;i </eesti>
<inglise> - to remove the active substance from the market, or </inglise>
<eesti> - k&otilde;rvaldada nimetatud toimeaine turult v&otilde;i </eesti>
<inglise> - to suspend the active substance from the market, with the option of reconsidering the inclusion of the active substance in Annex I after submission of the results of additional trials or of additional information specified in the report, or </inglise>
<eesti> - peatada ajutiselt toimeaine turustamine, j&auml;ttes v&otilde;imaluse k&otilde;nealuse toimeaine kandmist I lisasse uuesti kaaluda p&auml;rast lisakatsete tulemuste v&otilde;i aruandes kindlaksm&auml;&auml;ratud t&auml;iendavate andmete esitamist, v&otilde;i </eesti>
<inglise> - to postpone any decision on possible inclusion pending the submission of the results of additional trials or information specified in the report. </inglise>
<eesti> - l&uuml;kata k&otilde;ik aine v&otilde;imalikku lisasse kandmist k&auml;sitlevad otsused edasi, kuni lisakatsete tulemused v&otilde;i aruandes kindlaksm&auml;&auml;ratud andmed on esitatud. </eesti>
<inglise> 2. </inglise>
<eesti> 2. </eesti>
<inglise> From the start of the examination referred to in paragraph 1 (a), the rapporteur Member State may request the notifiers to improve the dossier, or add to it. </inglise>
<eesti> Alates l&otilde;ike 1 punktis a osutatud l&auml;bivaatamise algusest v&otilde;ib referentliikmesriik n&otilde;uda teatajatelt toimiku parandamist v&otilde;i t&auml;iendamist. </eesti>
<inglise> Moreover, the rapporteur Member State shall, during this examination, consult with experts from other Member States, accepted by the Commission on a proposal from the Member States concerned, with regard to the whole or certain parts of the dossier. </inglise>
<eesti> L&auml;bivaatamise jooksul konsulteerib referentliikmesriik kogu toimiku v&otilde;i selle konkreetsete osade suhtes ka teiste liikmesriikide ekspertidega, kes on komisjoni poolt kinnitatud asjaomaste liikmesriikide ettepanekul. </eesti>
<inglise> 3. </inglise>
<eesti> 3. </eesti>
<inglise> After receiving the summary dossier and the report referred to in paragraph 1, the Commission shall refer the dossier and the report to the Standing Committee on Plant Health for examination. </inglise>
<eesti> P&auml;rast koondtoimiku ja l&otilde;ikes 1 nimetatud aruande saamist saadab komisjon need alalisele taimetervise komiteele l&auml;bivaatamiseks. </eesti>
<inglise> After that examination, the Commission shall, without prejudice to any proposal it may submit with a view to amending the Annex to Directive 79/117/EEC, present to the Committee either a draft directive to include the active substance in Annex I to the Directive, setting out (where appropriate) the conditions for such inclusion, or else a draft decision pursuant to the final subparagraph of Article 8 (2) of the Directive, whereby that active substance is not included in Annex I thereto. </inglise>
<eesti> Ilma et see piiraks direktiivi 79/117/EM&Uuml; lisa v&otilde;imalikke muutmisettepanekuid, esitab komisjon p&auml;rast k&otilde;nealust l&auml;bivaatamist komiteele kas toimeaine direktiivi I lisasse kandmise otsuse projekti, milles (vajaduse korral) on ette n&auml;htud teatavad tingimused, v&otilde;i otsuse projekti vastavalt direktiivi artikli 8 l&otilde;ike 2 viimasele l&otilde;igule, mille kohaselt toimeainet selle I lisasse ei kanta. </eesti>
<inglise> 4. </inglise>
<eesti> 4. </eesti>
<inglise> However, where, following the examination referred to in paragraph 3, the submission of the results of certain additional trials or of additional information is required, the Commission shall determine: </inglise>
<eesti> Kui p&auml;rast l&otilde;ikes 3 osutatud l&auml;bivaatamist on siiski tarvis esitada teatavate lisakatsete tulemused v&otilde;i t&auml;iendavad andmed, m&auml;&auml;rab komisjon kindlaks: </eesti>
<inglise> - the time-limit within which the results or information concerned must be submitted to the rapporteur Member State and the experts designated according to paragraph 2 above, </inglise>
<eesti> - t&auml;htaja, mille jooksul asjaomased tulemused v&otilde;i andmed tuleb esitada referentliikmesriigile ning l&otilde;ike 2 kohaselt m&auml;&auml;ratud ekspertidele, </eesti>
<inglise> - the time-limit within which the notifiers concerned must communicate to the rapporteur Member State and to the Commission their undertaking to submit the required results or information within the time-limit laid down in the first indent. </inglise>
<eesti> - t&auml;htaja, mille jooksul k&otilde;nealused teatajad peavad teatama referentliikmesriigile ja komisjonile oma kohustusest esitada n&otilde;utud tulemused v&otilde;i andmed esimeses taandes s&auml;testatud t&auml;htaja jooksul. </eesti>
<inglise> 5. </inglise>
<eesti> 5. </eesti>
<inglise> The Commission shall submit to the Committee a draft decision for non-inclusion in Annex I to the Directive. In accordance with the final subparagraph of Article 8 (2) thereof, where: </inglise>
<eesti> Komisjon esitab komiteele otsuse projekti direktiivi I lisasse kandmataj&auml;tmise kohta koosk&otilde;las direktiivi artikli 8 l&otilde;ike 2 viimase l&otilde;iguga, kui: </eesti>
<inglise> - the notifiers concerned have not communicated their undertaking to submit the required results within the time limit referred to in the second indent of paragraph 4, </inglise>
<eesti> - k&otilde;nealused teatajad ei ole teatanud oma kohustusest esitada n&otilde;utud tulemused l&otilde;ike 4 teises taandes osutatud t&auml;htaja jooksul, </eesti>
<inglise> - the rapporteur Member State has informed the Commission that the results referred to in the first indent of paragraph 4 have not been submitted within the time limit laid down. </inglise>
<eesti> - referentliikmesriik on teavitanud komisjoni sellest, et l&otilde;ike 4 esimeses taandes osutatud tulemusi ei ole esitatud etten&auml;htud t&auml;htaja jooksul. </eesti>
<inglise> Article 8 </inglise>
<eesti> Artikkel 8 </eesti>
<inglise> 1. </inglise>
<eesti> 1. </eesti>
<inglise> After receiving the results of the additional trials or the additional information, the rapporteur Member State must: </inglise>
<eesti> P&auml;rast lisakatsete tulemuste v&otilde;i t&auml;iendavate andmete saamist peab referentliikmesriik: </eesti>
<inglise> (a) examine it in conjunction with the results of the dossier already submitted for the substance concerned; </inglise>
<eesti> a) vaatama need l&auml;bi, v&otilde;ttes arvesse asjaomase aine kohta toimikus juba esitatut; </eesti>
<inglise> (b) immediately after such examination, ensure that the summary of the additional trials and the results of those trials or the additional information are sent by the notifier to the other Member States and to the Commission; </inglise>
<eesti> b) tagama kohe p&auml;rast l&auml;bivaatamist, et teataja saadaks lisakatsete kokkuv&otilde;tte ja nende tulemused v&otilde;i t&auml;iendavad andmed teistele liikmesriikidele ning komisjonile; </eesti>
<inglise> (c) communicate as quickly as possible, and within nine months at the latest following receipt of the results or information, to the Commission, the report of its assessment of the whole dossier including a recommendation: </inglise>
<eesti> c) edastama komisjonile v&otilde;imalikult kiiresti ja hiljemalt &uuml;heksa kuu jooksul p&auml;rast tulemuste v&otilde;i andmete saamist kogu toimiku hindamisaruande, mis sisaldab &uuml;ht j&auml;rgmistest soovitustest: </eesti>
<inglise> - to include the active substance in Annex I stating the conditions for such inclusion, </inglise>
<eesti> - kanda toimeaine I lisasse, t&auml;psustades tingimused, </eesti>
<inglise> - where the substance is already included in Annex I, to maintain or amend the conditions for inclusion, or </inglise>
<eesti> - s&auml;ilitada tingimused v&otilde;i muuta neid, kui nimetatud aine on juba kantud I lisasse, </eesti>
<inglise> - to remove the active substance from the market, or </inglise>
<eesti> - k&otilde;rvaldada nimetatud toimeaine turult, </eesti>
<inglise> - to suspend the active substance from the market, with the option of reconsidering the inclusion of the active substance in Annex I after submission of certain additional trials or information in order to clarify any inconclusive points resulting from the additional trials or information submitted in accordance with Article 7 (4); </inglise>
<eesti> - peatada ajutiselt toimeaine turustamine, j&auml;ttes v&otilde;imaluse k&otilde;nealuse toimeaine kandmist I lisasse uuesti kaaluda p&auml;rast teatavate lisakatsete v&otilde;i t&auml;iendavate andmete esitamist, et selgitada v&auml;lja k&otilde;ik artikli 7 l&otilde;ike 4 kohaselt esitatud lisakatsetest v&otilde;i andmetest tulenevad ebaselged punktid; </eesti>
<inglise> - or, where the results of the additional trials or information do not permit definite conclusions to be drawn, to postpone the decision pending the submission of certain further trials in order to clarify any inconclusive points resulting from the additional trials submitted in accordance with Article 7 (4). </inglise>
<eesti> - kui lisakatsete tulemused v&otilde;i andmed ei v&otilde;imalda kindlate j&auml;relduste tegemist, l&uuml;kata otsustamine edasi kuni j&auml;rgmiste katsetulemuste esitamiseni, et selgitada v&auml;lja k&otilde;ik artikli 7 l&otilde;ike 4 kohaselt esitatud lisakatsetest tulenevad ebaselged punktid. </eesti>
<inglise> 2. </inglise>
<eesti> 2. </eesti>
<inglise> The procedure provided for in Article 7 (2) is applicable to the examinations referred to in paragraph 1 (a) hereof. </inglise>
<eesti> K&auml;esoleva artikli l&otilde;ike 1 punktis a osutatud l&auml;bivaatamiste suhtes kohaldatakse artikli 7 l&otilde;ikes 2 etten&auml;htud korda. </eesti>
<inglise> 3. </inglise>
<eesti> 3. </eesti>
<inglise> After receiving the summary and report referred to in paragraph 1, the Commission shall refer them to the Committee for examination in the light of the examination already carried out in accordance with the first subparagraph of Article 7 (3). </inglise>
<eesti> P&auml;rast l&otilde;ikes 1 osutatud kokkuv&otilde;tte ja aruande saamist saadab komisjon need komiteele l&auml;bivaatamiseks, kes v&otilde;tab arvesse artikli 7 l&otilde;ike 3 esimese l&otilde;igu kohaselt juba toimunud l&auml;bivaatamist. </eesti>
<inglise> After this examination, the Commission shall, without prejudice to any proposal it may submit with a view to amending the Annex to Directive 79/117/EEC, present to the Committee either a draft decision to include the active substance in Annex I to the Directive, setting out (where appropriate) the conditions for such inclusion, or else a draft decision pursuant to the final subparagraph of Article 8 (2) of the Directive, whereby that active substance is not included in Annex I thereto. </inglise>
<eesti> Ilma et see piiraks direktiivi 79/117/EM&Uuml; lisa v&otilde;imalikku muutmisettepanekut, esitab komisjon p&auml;rast k&otilde;nealust l&auml;bivaatamist komiteele kas toimeaine direktiivi I lisasse kandmise otsuse projekti, milles (vajaduse korral) on ette n&auml;htud teatavad tingimused, v&otilde;i otsuse projekti vastavalt direktiivi artikli 8 l&otilde;ike 2 viimasele l&otilde;igule, mille kohaselt toimeainet selle I lisasse ei kanta. </eesti>
<inglise> In the case of an active substance already listed in the said Annex, the draft decision may amend the conditions governing inclusion. </inglise>
<eesti> K&otilde;nealuses lisasse juba kantud toimeaine puhul v&otilde;ib otsuse projektiga muuta selle lisasse kandmise tingimusi. </eesti>
<inglise> 4. </inglise>
<eesti> 4. </eesti>
<inglise> Where, following the examination by the Committee referred to in the first subparagraph of paragraph 3 above, the results of further trials appear necessary, Article 7 (4) and (5) and Article 8 (1) shall apply. </inglise>
<eesti> Kui p&auml;rast l&otilde;ike 3 esimeses l&otilde;igus osutatud l&auml;bivaatamist komitee poolt osutuvad vajalikuks edasised katsetulemused, kohaldatakse artikli 7 l&otilde;ikeid 4 ja 5 ning artikli 8 l&otilde;iget 1. </eesti>
<inglise> In such cases, the Commission shall give the notifiers concerned its detailed reasons for requesting additional trials. </inglise>
<eesti> Sel juhul p&otilde;hjendab komisjon teatajatele &uuml;ksikasjalikult lisakatsete vajalikkust. </eesti>
<inglise> Article 9 </inglise>
<eesti> Artikkel 9 </eesti>
<inglise> Where, in respect of a substance mentioned in Annex A, the Commission presents a proposal for a total prohibition under Directive 79/117/EEC, the periods provided in this Regulation shall be suspended until a decision on this proposal has been taken. </inglise>
<eesti> Kui komisjon teeb A lisas nimetatud aine kohta ettepaneku keelustada see t&auml;ielikult direktiivi 79/117/EM&Uuml; alusel, peatatakse k&auml;esoleva m&auml;&auml;rusega etten&auml;htud t&auml;htajad seni, kuni k&otilde;nealuse ettepaneku kohta on tehtud otsus. </eesti>
<inglise> Where the Council decides on the total prohibition of the substance in the Annex to Directive 79/117/EEC, the procedure under this Regulation will be terminated. </inglise>
<eesti> Kui n&otilde;ukogu otsustab direktiivi 79/117/EM&Uuml; lisasse kantud aine t&auml;ielikult keelustada, l&otilde;petatakse k&auml;esoleva m&auml;&auml;ruse kohane menetlus. </eesti>
<inglise> Article 10 </inglise>
<eesti> Artikkel 10 </eesti>
<inglise> This Regulation shall enter into force on 1 February 1993. </inglise>
<eesti> K&auml;esolev m&auml;&auml;rus j&otilde;ustub 1. veebruaril 1993. </eesti>
<inglise> This Regulation shall be binding in its entirety and directly applicable in all Member States. </inglise>
<eesti> K&auml;esolev m&auml;&auml;rus on tervikuna siduv ja vahetult kohaldatav k&otilde;ikides liikmesriikides. </eesti>
<inglise> Done at Brussels, 11 December 1992. </inglise>
<eesti> Br&uuml;ssel, 11. detsember 1992 </eesti>
<inglise> For the Commission </inglise>
<eesti> Komisjoni nimel komisjoni liige Ray MAC SHARRY </eesti>
<inglise> Ray MAC SHARRY Member of the Commission </inglise>
<eesti> (1) E&Uuml;T L 230, 19.08.1991, lk 1, parandatud E&Uuml;T-s L 170, 25.06.1992, lk 40. </eesti>
 